Tocqueville Asset Management L.P. Bridge Bio Pharma, Inc. Transaction History
Tocqueville Asset Management L.P.
- $6.27 Billion
- Q4 2024
A detailed history of Tocqueville Asset Management L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 18,975 shares of BBIO stock, worth $666,212. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,975
Previous 17,700
7.2%
Holding current value
$666,212
Previous $450,000
15.56%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BBIO
# of Institutions
320Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$887 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$882 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$529 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$437 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$217 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.2B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...